|
Volumn 104, Issue 5, 2015, Pages 1097-1098
|
Ovarian cortex transplantation: Time to move on from experimental studies to open clinical application
a b,c d d,e |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CHEMOTHERAPY;
CANCER THERAPY;
CLINICAL PRACTICE;
CRYOPRESERVATION;
EXPERIMENTAL STUDY;
FEMALE;
FEMALE FERTILITY;
FERTILITY PRESERVATION;
HEALTH CARE PERSONNEL;
HEMATOLOGIST;
HUMAN;
NOTE;
ONCOLOGIST;
ORGAN TRANSPLANTATION;
OVARIAN CORTEX TRANSPLANTATION;
OVARY INSUFFICIENCY;
PATIENT REFERRAL;
PREMATURE OVARIAN FAILURE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
AGONISTS;
ANIMAL;
DRUG EFFECTS;
FERTILITY;
INFERTILITY, FEMALE;
LIVE BIRTH;
OVARY;
PATHOPHYSIOLOGY;
PREGNANCY;
PREGNANCY RATE;
PROCEDURES;
TRANSPLANTATION;
TREATMENT OUTCOME;
FERTILITY PROMOTING AGENT;
GONADORELIN;
ANIMALS;
FEMALE;
FERTILITY;
FERTILITY AGENTS, FEMALE;
FERTILITY PRESERVATION;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
INFERTILITY, FEMALE;
LIVE BIRTH;
OVARY;
PREGNANCY;
PREGNANCY RATE;
TREATMENT OUTCOME;
|
EID: 84945978322
PISSN: 00150282
EISSN: 15565653
Source Type: Journal
DOI: 10.1016/j.fertnstert.2015.08.005 Document Type: Editorial |
Times cited : (144)
|
References (7)
|